Mitochondrial bioenergetic machinery (OXPHOS)

The mitochondrial bioenergetic machinery is the fundamental cellular system responsible for generating adenosine triphosphate (ATP) through oxidative phosphorylation (OXPHOS) [1, 4]. It comprises the electron transport chain (Complexes I-IV) and ATP synthase (Complex V), which utilize a proton gradient across the inner mitochondrial membrane to drive energy production [4, 17]. Beyond its role as the 'powerhouse of the cell,' this machinery is a central regulator of cellular redox state, calcium signaling, and the initiation of programmed cell death [6, 18]. Dysfunctional bioenergetics are implicated in a wide range of diseases, including primary mitochondrial disorders, neurodegeneration, and metabolic syndromes like type 2 diabetes [1, 9, 17]. In oncology, the machinery is often hijacked to support the high metabolic demands of tumor cells and chemoresistance, making it a significant target for novel 'mitocan' therapeutics and repurposed drugs like metformin and tigecycline [8, 11, 13]. However, therapeutic targeting of this system is complicated by the risk of off-target toxicity in high-energy tissues such as the heart and brain [7, 14].

Other names

Oxidative phosphorylation systemMitochondrial respiratory chainElectron transport chainMitochondrial energy machineryOXPHOS machinery

Inhibition of electron transport chain complexes, uncoupling of oxidative phosphorylation, inhibition of mitochondrial protein translation, and modulation of mitochondrial membrane potential to alter ATP production and reactive oxygen species levels.